Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec 26.
doi: 10.1186/s12889-025-26025-5. Online ahead of print.

Utilisation of HIV pre-exposure prophylaxis and preferences of alternative long-acting modalities among men who have sex with men in Hong kong: a cross-sectional study

Tsz Ho Kwan  1   2   3 , Denise Pui Chung Chan  2   3 , Shui Shan Lee  4   5
Affiliations
Free article

Utilisation of HIV pre-exposure prophylaxis and preferences of alternative long-acting modalities among men who have sex with men in Hong kong: a cross-sectional study

Tsz Ho Kwan et al. BMC Public Health. .
Free article

Abstract

Background: Pre-exposure prophylaxis (PrEP) has changed the paradigm of HIV prevention. A majority of men who have sex with men (MSM) were using oral tablets; meanwhile alternative long-acting modalities have been and are being developed. We aimed to assess the prevalence of PrEP use and the preferences of potential long-acting PrEP in the MSM community in Hong Kong, an Asian Pacific city where free or subsidised PrEP is not available.

Methods: A cross-sectional study was conducted using an online self-administered questionnaire. Eligible participants were adult MSM without HIV infection who normally resided in Hong Kong. Historical and current PrEP use, and preferences of using long-acting injectable for PrEP were tested against sociodemographic and sexual behavioural factors using chi-squared test and multivariable logistic regression model.

Results: Of the 437 responses collected, 17% had ever used PrEP and 16% were currently using PrEP. Current PrEP users were more likely to have a higher income level (adjusted odds ratio [aOR] 2.11, p = 0.04), have engaged in chemsex (aOR 4.02, p < 0.01), have a non-regular male sex partner (aOR 2.66, p = 0.02), have a male sex partner living with HIV (aOR 3.60, p < 0.01), and be inclined to have condomless sex in the future (aOR 6.86, p < 0.01). Among ever users, MSM who discontinued PrEP had a lower sexual risk than current users, such as recent history of chemsex (OR 0.22, p < 0.01) and inclination to have condomless sex (OR 0.15, p < 0.01). Long-acting injectables were accepted by 27% MSM, who were more likely to be current PrEP users (odds ratio [OR] 2.35, p < 0.01), concerned about efficacy (OR 1.66, p = 0.03), and expecting to use PrEP for more than 2 years in the future (OR 9.69, p < 0.01).

Conclusion: The higher prevalence of PrEP among MSM indicated an increased awareness over the past decade. However, its promotion could have been hindered by the absence of a publicly funded or subsidised programme. While PrEP users had a higher sexual risk, the utilisation pattern would be affected by the dynamicity of sexual activities. Long-acting injectables had a moderate acceptance rate. Current PrEP users and those anticipated long-term users could be prioritised for its promotion.

Keywords: Injectable; Long-acting PrEP; Men who have sex with men; Pre-exposure prophylaxis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was approved by The Chinese University of Hong Kong Survey and Behavioural Research Ethics Committee (Ref. No. SBRE-21-0470). All participants gave online informed consent before participation. Consent for publication: Not applicable. Competing interests: THK is an Editorial Board Member of BMC Public Health. We declare no other competing interests.

References

    1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV. iPrEx study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.
    1. Kwan TH, Wong NS, Lui GCY, Chan KCW, Tsang OTY, Leung WS, Ho KM, Lee MP, Lam W, Chan SN, Chan DPC, Lee SS. Incorporation of information diffusion model for enhancing analyses in HIV molecular surveillance. Emerg Microbes Infect. 2020;9(1):256–62.
    1. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Préau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Doré V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF, ANRS IPERGAY Study Group. On-Demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.
    1. Kwan TH, Lui GCY, Lam TTN, Lee KCK, Wong NS, Chan DPC, Lee SS. Comparison between daily and on-demand PrEP (pre-exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong kong: A randomized, controlled, open-label, crossover trial. J Int AIDS Soc. 2021;24(9):e25795.
    1. Wong NS, Chan DP, Kwan TH, Lui GC, Lee KC, Lee SS. Dynamicity of HIV Pre-exposure prophylaxis usage pattern and association with executed adherence in MSM: an implementation study in Hong Kong. AIDS Behav. 2024;28(4):1327–44.

LinkOut - more resources